ARID1A gene silencing reduces the sensitivity of ovarian clear cell carcinoma to cisplatin

In ovarian clear cell carcinoma (OCCC), the mutation rate of the AT-rich interaction domain 1A (ARID1A) gene is 46–57%. However, the effects of ARID1A gene silencing by small interfering RNA (siRNA) on the sensitivity of OCCC to cisplatin have not been investigated. Thus, this study aimed to elucida...

Full description

Saved in:
Bibliographic Details
Published in:Exp Ther Med
Main Authors: Lyu, Changshuai, Zhang, Yinglan, Zhou, Xingnan, Lang, Jinghe
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2016
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228580/
https://ncbi.nlm.nih.gov/pubmed/28105136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3863
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items